
Consumer Discretionary · Apparel, Accessories & Luxury Goods
$133.82
-2.82%
Vol: 3.7M
Friday, May 1, 2026
Lululemon hired former Nike executive Heidi O'Neill as next CEO in April 2026 but stock fell 13% on announcement. Company facing governance turmoil with founder Chip Wilson issuing shareholder letter stating investment in trouble and board doesn't understand business. Wilson seeking support for three independent board nominees at 2026 Annual Meeting. Stock down 30% YTD and 45% over past 12 months at 52-week low of $136.98. Analysts project 35% decline in next-quarter EPS. FY26 guidance targets only 2-4% revenue growth to $11.35-11.50B, missing "Power of Three x2" target of $12.5B. Jefferies cut PT to $145 from $170 on April 28. Disclosure shows Wilson advised competitors Alo and Vuori. Consensus expects turnaround delayed until 2027.
Lululemon appointed Heidi O'Neill, former Nike executive with 27 years at Nike, as Chief Executive Officer effective September 8, 2026, but stock fell 13% on the announcement. The company is navigating significant challenges including a proxy fight from founder Chip Wilson and $1B activist stake from Elliott Management. Jefferies lowered price target to $145 from $170 with Hold rating. The stock has declined 30% YTD and trades at $137.30, down nearly 12% over the past week amid product concerns and competitive pressure.
Lululemon faces investigation from Texas attorney general examining whether athletic apparel contains PFAS or forever chemicals linked to health problems. The company phased out PFAS use in fiscal 2023, contrary to the probe. Lululemon reported FY25 sales of $10.6 billion, up 10% from prior year, but earnings exceeded EPS expectations while revenue guidance missed. Founder Dennis J. Wilson launched social media and search engine advertisements ahead of the shareholder meeting advocating for board changes. The company currently operates without a permanent CEO as it searches for a replacement. Stock has declined 22.8% year-to-date and 34.7% over the past year, trading at $160.60 USD on April 15, 2026. Next earnings release scheduled May 28, 2026.
The Texas Attorney General's office launched a civil investigation into Lululemon for alleged use of 'forever chemicals' (PFAS) in athletic apparel and potential consumer misleading about product safety. The company stated it phased out PFAS use in fiscal 2023, though internal documents suggest early 2024. The investigation has sparked significant debate on Chinese social media, a key growth market for the brand. The stock fell 3-4.5% following the probe announcement. Lululemon faces additional headwinds from a CEO vacancy and activist messaging around shareholder governance.
Texas Attorney General Ken Paxton issued Civil Investigative Demand April 13 investigating whether Lululemon misled consumers about product safety regarding PFAS. This follows 4.8% surge on April 10 after 2026 Action Plan showed stronger sell-through rates (+25%). Faces $275M tariff costs expected to rise to $380M. Stock at $163.86.
Lululemon issued Q1 2026 EPS guidance of $1.630-$1.680 (vs consensus $2.180). Stock surged 4.8% after management revealed spring 2026 collection showing 25% higher sell-through. CEO Andre Maestrini purchased 3,275 shares on April 1 at $151.02, signaling confidence. Headwinds include tariffs adding $275M costs.
Q1 guidance: EPS $1.63-$1.68 vs consensus $2.18. Co-CEO purchased 3,275 shares. Stock up 3.21%. Q1 earnings May 28.
Lululemon reported weak Q4 2025 guidance with 2026 sales forecast $11.35B-$11.50B (below $11.52B consensus) and EPS guidance $12.10-$12.30 (below $12.58 estimate). Americas same-store sales expected down 1%-3% in 2026 after stagnation for two years. China sales forecasted to grow ~20%; rest of world mid-teens. Interim Co-CEO Andre Maestrini purchased 3,275 shares signaling internal confidence despite headwinds from tariffs, higher expenses, and ongoing proxy battle with founder Chip Wilson. Recent insider share purchase sparked 7.1% weekly rally.
Lululemon President Andre Maestrini bought 3,275 shares on April 1 for $494,590, signaling internal confidence. Company faces mixed valuation signals and leadership volatility. FY2026 guidance: $11.35-11.50B revenue, $12.10-12.30 EPS. Stock down 2.48% in 24h.
Lululemon Athletica (LULU) beat Q4 estimates but issued FY2026 EPS guidance of $12.10-$12.30 (down 8% from FY2025's $13.26). Stock down 36% YoY due to tariff impacts and declining margins. Analyst views mixed: 28 'Hold', 3 'Buy', 2 'Sell'. Price target $206.77 (22% upside). Recent insider purchase by president (3,275 shares) signals confidence. Stock at $154.71, down 9.9% monthly.
Founder Dennis Wilson and affiliates filed preliminary proxy statement on March 27, 2026 seeking to elect new board members and declassify the board. Company reported Q4 FY2025 earnings beat at $5.01 EPS vs $4.79 consensus but guidance missed expectations. Recent analyst downgrades: Citi cut to $185 from $210; UBS to $176 from $189. Insider buying: President Andre Maestrini purchased 3,275 shares on April 1.
Lululemon faces activist investor Dennis J. Wilson's group seeking to elect three board members, representing 8.6% ownership. Citi lowered target to $185, UBS cut to $176. Stock at $156.84, down 43.94% YoY. The company authorized $1 billion stock repurchase increase. Activist campaign adds execution risk ahead of annual meeting.
Lululemon Athletica reported Q4 2025 results with mixed performance and lower earnings, prompting analyst downgrades. Founder Chip Wilson filed a proxy statement on March 27, 2026 seeking board changes including new directors Laura Gentile, Eric Hirshberg, and Marc Maurer, and board declassification. Citi lowered price target to $185 from $210 and UBS cut to $176 from $189 on growth concerns. Stock traded at $155.72 on April 2, down 1.16% in 24 hours and down 43.94% over the past year. Company completed multi-year share repurchase program but faces execution risks.
Lululemon Athletica reported Q4 earnings on March 17, triggering significant analyst downgrades. Citigroup cut price target from $210 to $185, BNP Paribas from $206 to $170, and UBS from $189 to $176. The stock declined to the $143-$150 range. Leadership transitions and declining profitability pressured sentiment.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| NKENIKE | $44.49 | +0.28% | +0.8% | 24.0x | 1.32 | $65.7B |
| TPRTAPESTRY | $142.79 | -1.55% | +0.9% | 20.1x | 1.61 | $29.7B |
| RLRALPH | $362.14 | +0.98% | +0.0% | 19.9x | 1.48 | $21.7B |
| LULULULULEMON | $133.82 | -2.82% | -11.8% | 10.4x | 1.07 | $16.2B |
| AMZNAMAZON.COM | $268.12 | +1.15% | +24.6% | 27.1x | 1.38 | $2.85T |
| TSLATESLA | $390.70 | +2.38% | +8.2% | 150.5x | 1.92 | $1.43T |
Price below 200d MA — bearish structure.